Skip to content

AdaptHealth AHCO EPS (Diluted)

EPS (Diluted) at other companies

CVS Health logo
CVS HealthCVS
$2.30+63.1%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$0.67+379%
Aveanna Healthcare Holdings Inc. logo
Aveanna Healthcare Holdings Inc.AVAH
$0.19+533%
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
$0.24+9.1%
Encompass Health Corporation logo
Encompass Health CorporationEHC
$1.93+30.4%
GHC
Graham HoldingsGHC
$6.62+21.5%

Other financials

Income statement

See full
Revenue$819.8M+5.4%
Gross profit$111.5M-7.4%
Operating income$5.5M-76.3%
Net income-$16.0M-123%

Balance sheet

See full
Cash & equivalents$48.0M-10.6%
Total debt$2.0B-4.9%
Total equity$1.5B-3.9%
Total assets$4.4B-0.3%

Cash flow

See full
Operating cash flow$93.7M-1.9%
CapEx$121.2M+26.8%
Free cash flow-$27.5M-47,297%

Valuation

See full
Market cap$1.36B+10.6%
Enterprise value$3.32B+1.7%
P/S0.4×0.0×

Profitability

See full
Gross margin18.3%-1.6pp
Operating margin8%+6.9pp
Net margin-2.4%-5.1pp
FCF margin5.8%-2.6pp

Returns & leverage

See full
Return on equity-5.2%-10.8pp
Debt / equity1.3×0.0×
Current ratio0.9×-0.4×

Where this comes from

Reported directly by AdaptHealth in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: AdaptHealth’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about AdaptHealth's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AdaptHealth's EPS (diluted)?
AdaptHealth (AHCO) reported EPS (diluted) of -$0.12 in Q1 2026.
How has AdaptHealth's EPS (diluted) changed year-over-year?
AdaptHealth's EPS (diluted) decreased by 140.0% year-over-year, from -$0.05 to -$0.12.
What is the long-term trend for AdaptHealth's EPS (diluted)?
Over 4 years (2021 to 2025), AdaptHealth's EPS (diluted) has grown at a -5.1% compound annual growth rate (CAGR), from $0.64 to -$0.52.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.